文献速递胃肠动力与功能性疾病

离散选择实验显示肠易激综合征患者强烈偏好饮食治疗

Discrete Choice Experiment Reveals Strong Preference for Dietary Treatment Among Patients With Irritable Bowel Syndrome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-02-16

该研究邀请马斯特里赫特IBS队列427例患者参与离散选择实验,最终185例(43.3%)完成问卷。结果显示最受偏好的是饮食干预(48.1%),其次为药物治疗(29.2%)和心理治疗(22.7%);年轻患者(≤50岁)偏好饮食干预和较长复发间隔,年长患者(>50岁)更倾向药物治疗且复发间隔不重要。

要点

  • IBS患者最偏好饮食干预(48.1%),其次为药物治疗(29.2%)和心理治疗(22.7%)。
  • 患者偏好更高疗效、更短起效时间、更长复发间隔、无严重副作用及心理治疗时更频繁就诊。
  • ≤50岁患者偏好饮食干预和长复发间隔,>50岁患者更倾向药物治疗且复发间隔不重要。

核心结论

  • 饮食干预是IBS患者最偏好的治疗方式。
  • 在共享决策中识别患者治疗偏好可提供更优管理策略,并可能是减轻疾病负担的最佳方法。

研究设计与样本

  • 研究邀请马斯特里赫特IBS队列的427例患者参与。
  • 采用标记离散选择实验问卷,包含9个情景,每个情景有3个备选方案(药物治疗、饮食、心理治疗)。
  • 治疗情景基于6个属性:有效性、起效时间、至复发时间、副作用、所需时间、就诊频率。
  • 采用混合logit模型分析偏好权重和相对重要性。

主要发现

  • 427例潜在应答者中185例(43.3%)完成问卷,平均年龄49.51岁,女性占69.2%。
  • 最受偏好的治疗为饮食干预(48.1%),其次为药物治疗(29.2%)和心理治疗(22.7%)。
  • IBS患者偏好更高有效性、更短起效时间、更长至复发时间、无严重副作用,以及接受心理治疗时更频繁的就诊。
  • 年轻患者(≤50岁)偏好饮食干预和较长至复发时间。
  • 年长患者(>50岁)更倾向选择药物治疗,且至复发时间不重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder of the gut-brain interaction that significantly affects quality of life. Several treatments, with comparable clinical efficacy, are available. Patient preferences can therefore be an important determinant of an effective management strategy. Treatment preferences of patients regarding decision making remain unclear. We aimed to examine these preferences and estimate trade-offs between different attributes. METHODS: A total of 427 patients from the Maastricht IBS cohort were invited to participate. A labeled discrete choice experiment survey, containing 9 scenarios with each 3 alternatives (medication, diet, psychotherapy), was developed in order to estimate preferences. The treatment scenarios were based on 6 attributes: effectiveness, time to response, time until recurrence, side effects, time required, and frequency of appointments. The preference weights and relative importance were analyzed using a mixed logit model. RESULTS: A total of 185 (43.3%) of 427 potential respondents completed the questionnaire (mean age 49.51 years, 69.2% female). The most preferred treatment was dietary intervention (48.1%), followed by pharmacotherapy (29.2%) and psychotherapy (22.7%). IBS patients preferred a higher effectiveness, shorter time interval to response, longer time interval until recurrence, no severe side effects, and frequent appointments when attending psychotherapy. Younger patients (≤50 years of age) preferred dietary interventions and a long period until recurrence, whereas older patients (>50 years of age) were more inclined to choose pharmacotherapy and the period until recurrence was not important. CONCLUSIONS: Dietary interventions were the most preferred IBS therapy. Identifying patients' treatment preferences during shared decision making will provide more optimal management strategies and could be the best approach to diminish disease burden.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sturkenboom R, Keszthelyi D, Masclee AAM, et al. Discrete Choice Experiment Reveals Strong Preference for Dietary Treatment Among Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2022. PMID: 35181571. doi:10.1016/j.cgh.2022.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。